fatty acid oxidation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-15 and is reviewed periodically as new material appears.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport; not approved as medicine | Listed by WADA at all times. |
| Common synonyms | GW501516, GW-501516, endurobol | Cardarine is a colloquial name. |
| Typical analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Common test matrix | Urine | Blood and dried blood spots also possible. |
| Legal classification | Varies by country | Often treated as unapproved drug or research chemical. |
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
March 4, 2009: Malaysia Malaysia has a 50% chance of slipping into the recession as growth is expected to reach just 0.5% for the year, said the executive director Datuk Mohamed Ariff Abdul Kareem of the Malaysian Institute of Economic Research.
Because MS lesions can affect any part of the central nervous system, a person with MS can have almost any neurological signs or symptoms. Fatigue is one of the most common symptoms of MS. Roughly 65% of people with MS experience fatigue. Of these, some 15–40% report fatigue as their most disabling symptom. Autonomic, visual, motor, and sensory problems are also among the most common symptoms. The specific symptoms depend on the locations of the lesions within the nervous system and may include loss of sensitivity or changes in sensation in the limbs, such as tingling, "pins and needles", or numbness; limb motor weakness or pain, blurred vision, pronounced reflexes, muscle spasms, difficulty walking, or with coordination or balance (ataxia); problems with speech or swallowing, visual problems (optic neuritis manifesting as eye pain and vision loss, or nystagmus manifesting as double vision), fatigue, and bladder and bowel difficulties (such as urinary or fecal incontinence or retention), among others. When MS is more advanced, walking difficulties lead to a higher risk of falling. Difficulties in thinking and emotional problems such as depression or unstable mood are also common. The primary deficit in cognitive function that people with MS experience is slowed information-processing speed, with memory also commonly affected, and executive function less commonly. Intelligence, language, and semantic memory are usually preserved, and the level of cognitive impairment varies considerably between people with MS.
=== N05CM Other hypnotics and sedatives === N05CM01 Methaqualone N05CM02 Clomethiazole N05CM03 Bromisoval N05CM04 Carbromal N05CM05 Scopolamine N05CM06 Propiomazine N05CM07 Triclofos N05CM08 Ethchlorvynol N05CM10 Hexapropymate N05CM11 Bromides N05CM12 Apronal N05CM13 Valnoctamide N05CM15 Methylpentynol N05CM16 Niaprazine N05CM18 Dexmedetomidine N05CM20 Diphenhydramine N05CM22 Promethazine N05CM25 Magnesium aspartate hydrobromide N05CM26 Magnesium glutamate hydrobromide N05CM27 Doxylamine
Sources: en.wikipedia.org
Endre Mester (1903–1984) was a Hungarian physician and pioneer of laser medicine, especially the use of low level laser therapy (LLLT). In 1967, only a few years after the first working laser was invented, he started his experiments with the effects of lasers on skin cancer. He is credited as the discoverer of positive biological effects of low power lasers, which have been advocated as alternative medicine for use in wound healing, smoking cessation, tuberculosis, temporomandibular joint disorders, and musculoskeletal conditions such as carpal tunnel syndrome, fibromyalgia, osteoarthritis, and rheumatoid arthritis. LLLT devices are popular and may bring about temporary relief of some types of pain. As of 2009, a summary from Quackwatch reported medical authorities found no reason to believe LLLT influence the course of any ailment or are more effective for pain control than other forms of heat delivery. Subsequent research has found LLLT may offer benefit in treating several health ailments, including rheumatoid arthritis, osteoarthritis, tendinopathy, and frozen shoulders.
Two-stroke chainsaws require about 2–5% of oil in the fuel to lubricate the engine, while the motor in electrical chain-saws is normally lubricated for life. Most modern gasoline-operated saws today require a fuel mix of 2% (1:50). Gasoline that contains ethanol can result in problems for the equipment because ethanol dissolves plastic, rubber, and other material. This leads to problems, especially on older equipment. A workaround for this problem is to run fresh fuel only and run the saw dry at the end of the work. Separate chain oil or bar oil is used for the lubrication of the bar and chain on all types of chainsaws. The chain oil is depleted because it tends to be thrown off by chain centrifugal force. On two-stroke chainsaws, the chain oil reservoir is usually filled up at the same time as refueling. The reservoir is normally large enough to provide sufficient chain oil between refueling. Lack of chain oil, or using an oil of incorrect viscosity, is a common source of damage to chainsaws, and tends to lead to rapid wear of the bar, or the chain seizing or coming off the bar. In addition to being quite thick, chain oil is particularly sticky (due to "tackifier" additives) to reduce the amount thrown off the chain. Although motor oil is a common emergency substitute, it is lost even faster, leaving the chain less lubricated. Oil is pumped from a small pump to a hole in the bar. From there, the lower ends of each chain drive link take a portion of the oil into the gauge towards the bar nose. The pump outlet and bar hole must be aligned.
Representatives Ro Khanna, a California Democrat, Thomas Massie, a Kentucky Republican and Marjorie Taylor Greene, a Georgia Republican and close ally of Trump, urged the House of Representatives to vote to release the full files. House Republican leaders offered an alternative vote to continue investigation by the House Oversight Committee. On September 3, President Trump spoke to reporters from the Oval Office, and said that the call for release of files is a "Democrat hoax that never ends". Similarly, CNN states that Democrats have "sought to weaponize the Epstein issue against Trump and the GOP in recent weeks, trying to force votes that would put vulnerable Republicans in difficult positions. But the tone of Wednesday's press conference was far less partisan." On October 7, Attorney General Bondi testified before the Senate Judiciary Committee and BBC drew five "takeaways" including "3. Bondi keen to focus on crime" and "4. But Democrats focus on Epstein". However, Senator John Kennedy (Republican - Louisiana) repeated comments from Commerce Secretary Howard Lutnick that Epstein was "the greatest blackmailer ever". On November 12, 2025, the petition to force a House vote for the release of the Epstein files by the Department of Justice secured the final required signature from Democratic Rep. Adelita Grijalva, the latter being sworn in for her position after the end of the October 2025 government shutdown. On the same day, House Democrats released a series of private emails between Epstein, Ghislaine Maxwell, and journalist Michael Wolff.
Sources: en.wikipedia.org
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.
Laboratories use liquid chromatography-tandem mass spectrometry to detect GW501516 and its metabolites. Urine is commonly tested, and testing can occur in and out of competition.
No, cardarine is not a SARM. It is a PPARδ agonist, which acts on a different receptor. The two classes are often confused in online discussions.
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.